OrbusNeich Medical Group Holdings (FRA:Q8T) Change In Receivables : €0.0 Mil (TTM As of Dec. 2024)

View and export this data going back to 2023. Start your Free Trial

What is OrbusNeich Medical Group Holdings Change In Receivables?

OrbusNeich Medical Group Holdings's change in receivables for the quarter that ended in Dec. 2024 was €0.0 Mil. It means OrbusNeich Medical Group Holdings's Accounts Receivable stayed the same from Jun. 2024 to Dec. 2024 .

OrbusNeich Medical Group Holdings's change in receivables for the fiscal year that ended in Dec. 2024 was €-6.3 Mil. It means OrbusNeich Medical Group Holdings's Accounts Receivable increased by €6.3 Mil from Dec. 2023 to Dec. 2024 .

OrbusNeich Medical Group Holdings's Accounts Receivable for the quarter that ended in Dec. 2024 was €39.8 Mil.

Days Sales Outstanding measures of the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed. OrbusNeich Medical Group Holdings's Days Sales Outstanding for the six months ended in Dec. 2024 was 89.29.

In Ben Graham's calculation of liquidation value, Apple Inc's Accounts Receivable are only considered to be worth 75% of book value. OrbusNeich Medical Group Holdings's liquidation value for the six months ended in Dec. 2024 was €259.2 Mil.

OrbusNeich Medical Group Holdings Change In Receivables Historical Data

The historical data trend for OrbusNeich Medical Group Holdings's Change In Receivables can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

OrbusNeich Medical Group Holdings Change In Receivables Chart

OrbusNeich Medical Group Holdings Annual Data

Trend

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

Change In Receivables

Get a 7-Day Free Trial

6.82

-1.92

-7.17

-2.15

-6.34

OrbusNeich Medical Group Holdings Semi-Annual Data
	Dec19	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23	Jun24	Dec24
Change In Receivables	Get a 7-Day Free Trial					-0.77	-	-	-	-

OrbusNeich Medical Group Holdings Change In Receivables Calculation

Change In Accounts Receivable relative to the previous period. It is any increase or decrease in the cash a company is owed by its customers.

Change In Receivables for the trailing twelve months (TTM) ended in Dec. 2024 adds up the semi-annually data reported by the company within the most recent 12 months, which was €0.0 Mil.

OrbusNeich Medical Group Holdings (FRA:Q8T) Change In Receivables Explanation

1. Accounts Receivable are created when a customer has received a product but has not yet paid for that product. Days Sales Outstanding measures of the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed.

OrbusNeich Medical Group Holdings's Days Sales Outstanding for the quarter that ended in Dec. 2024 is calculated as:

	Days Sales Outstanding
=	Accounts Receivable	/	Revenue	*	Days in Period
=	39.803	/	81.354	*	91
=	89.29

2. In Ben Graham's calculation of liquidation value, OrbusNeich Medical Group Holdings's accounts receivable are only considered to be worth 75% of book value:

OrbusNeich Medical Group Holdings's liquidation value for the quarter that ended in Dec. 2024 is calculated as:

	Liquidation Value
=	Cash, Cash Equivalents, Marketable Securities	-	Total Liabilities	+	(0.75 * Accounts Receivable)	+	(0.5 * Total Inventories)
=	237.403	-	34.985	+	0.75 * 39.803	+	0.5 * 53.794
=	259.2

OrbusNeich Medical Group Holdings Change In Receivables Related Terms

Thank you for viewing the detailed overview of OrbusNeich Medical Group Holdings's Change In Receivables provided by GuruFocus.com. Please click on the following links to see related term pages.

OrbusNeich Medical Group Holdings Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » OrbusNeich Medical Group Holdings Ltd (FRA:Q8T) » Definitions » Change In Receivables

Comparable Companies

Traded in Other Exchanges

06929:Hong Kong

Address

3rd Floor, Building 20E, Units 303 and 305, Hong Kong Science Park, Shatin New Town, Hong Kong, HKG

Website

https://www.orbusneich.com

OrbusNeich Medical Group Holdings Ltd is a China-based medical device maker of endovascular interventional instruments with majority reach. It launched its first research base in 2001 and was listed on the Hong Kong Exchange in 2022. As of 2023, OrbusNeich's majority revenue segment by geography is Japan with 24.7% of total revenue followed by Europe, the Middle East, and Africa, with 23.6% of total revenue. The Asia-Pacific region and the United States make up the balance. Its product segment is coronary interventional medical devices, such as scoring balloons, non-compliant balloons, or stents, together representing 82.7% of its total revenue.

OrbusNeich Medical Group Holdings Headlines

No Headlines